Group 1 - The core viewpoint of the news is that Aipeng Medical's stock has experienced significant fluctuations, with a year-to-date increase of 51.84% but a recent decline of 13.16% over the past five trading days [2] - As of November 19, Aipeng Medical's stock price was 26.67 yuan per share, with a market capitalization of 3.362 billion yuan [1] - The company has seen a net outflow of main funds amounting to 639.98 million yuan, with large orders accounting for 11.36% of total buying and 22.68% of total selling [1] Group 2 - Aipeng Medical's main business revenue composition includes 59.73% from pain management products, 29.40% from nasal and upper airway products, and 10.87% from other sources [2] - The company has been listed on the stock market since December 13, 2018, and is located in Rudong County, Jiangsu Province [2] - As of September 30, the number of shareholders decreased by 31.76% to 22,100, while the average circulating shares per person increased by 46.51% to 3,972 shares [3] Group 3 - For the period from January to September 2025, Aipeng Medical reported operating revenue of 252 million yuan, a year-on-year decrease of 8.41%, and a net profit attributable to the parent company of -11.4842 million yuan, a decrease of 401.64% [3] - The company has distributed a total of 113 million yuan in dividends since its A-share listing, with 16.3862 million yuan distributed over the past three years [4]
爱朋医疗跌2.09%,成交额5657.84万元,主力资金净流出639.98万元